AngioDynamics (NASDAQ: ANGO) today said it has completed the previously announced acquisition of certain assets of Microsulis Medical Ltd.Microsulis developed the Acculis MTA microwave ablation system, which utilizes a single, ...
Read more
Researchers from IBM (NYSE: IBM) and the Institute of Bioengineering and Nanotechnology revealed today an antimicrobial hydrogel that can break through diseased biofilms and completely eradicate drug-resistant bacteria upon ...
Read more
Stryker Corporation (NYSE: SYK) and Trauson Holdings Company Limited announced today that Stryker will make a voluntary general offer to acquire all the shares of Trauson for HK$7.50 per ordinary ...
Read more
Bristol-Myers Squibb Company (NYSE: BMY) and Abbott (NYSE: ABT) today announced results from a small, randomized Phase 2, open-label study in patients with previously-treated multiple myeloma that evaluated two doses ...
Read more
November 21, 2012 6:20 am by Gross, Charles | 0 Comments
The U.S. Food and Drug Administration has confirmed that aplastic anemia is a rare disease, a good sign for Pluristem's application for orphan drug status for its PLX ...
Read more
November 20, 2012 9:43 pm by Gross, Charles | 0 Comments
Supernus Pharmaceuticals (NASDAQ: SUPN) received positive topline results from its Phase IIb study on SPN-810 for the treatment of impulsive aggression in ADHD patients.The study is a multicenter randomized, double-blind, ...
Read more
November 16, 2012 6:53 pm by Gross, Charles | 0 Comments
Abiomed (NASDAQ: ABMD) today announced that a purported class action complaint was filed on November 16, 2012 in the United States District Court for the District of Massachusetts by Karse ...
Read more
November 14, 2012 6:17 am by Gross, Charles | 0 Comments
Mindray Medical (NYSE: MR) has initiated a voluntary recall affecting the A3/A5 Anesthesia Delivery System. Mindray has initiated this recall due to the possibility of a system leak resulting from ...
Read more
November 13, 2012 6:16 am by Gross, Charles | 0 Comments
Integra LifeSciences (NASDAQ: IART) announced today that on November 5, 2012 it received a warning letter from the United States Food and Drug Administration (FDA) related to quality systems issues ...
Read more
Raptor Pharmaceutical (NASDAQ: RPTP), today announced that the Company has acquired exclusive world-wide rights to intellectual property related to cysteamine and related compounds in the potential treatment of tissue fibrosis ...
Read more
Immunomedics (NASDAQ: IMMU), a biopharmaceutical company primarily focused on the development of monoclonal antibody-based products for the targeted treatment of cancer, autoimmune and other serious diseases, today announced the publication ...
Read more
Matrixx Initiatives announced today that it has increased its offer to acquire all of the outstanding shares of ProPhase Labs, Inc. (NASDAQ: PRPH) by 14.3% to $1.60 per share. The ...
Read more
September 28, 2012 11:18 pm by Gross, Charles | 0 Comments
The U.S. Food and Drug Administration has granted Boston Scientific Corporation (NYSE: BSX) regulatory approval for its S-ICD System, the world's first and only commercially available subcutaneous implantable defibrillator (S-ICD) ...
Read more
September 20, 2012 7:20 pm by Gross, Charles | 0 Comments
Amgen (NASDAQ: AMGN) today announced the U.S. Food and Drug Administration (FDA) approved a new indication for Prolia (denosumab) as a treatment to increase bone mass in men with osteoporosis ...
Read more
September 13, 2012 6:12 am by Gross, Charles | 0 Comments
Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) today announced that the company will be teaming up with The Myositis Association (TMA) to support research and educational initiatives in dermatomyositis and polymyositis."Questcor is ...
Read more
